The latest cancer drugs news
Browsing: Cancer Drug News
Cancer-causing gene triggered by alcohol may increase breast cancer risk
A University of Houston researcher and his team have discovered an important link between alcohol…
Two-pronged attack increases potency of new anti-cancer drugs
Walter and Eliza Hall Institute researchers have discovered that the treatment of the most deadly…
Research aims to better target treatment for young cancer patients
By Michelle Price. Thirty years ago any child diagnosed with paediatric malignancy would succumb to…
University of Canberra launches new cancer therapeutic company
The University of Canberra has established a new start-up company to commercialise a novel approach…
Interferon not beneficial for most stage III melanoma
Final results for the Sunbelt Melanoma Trial, published online this month in the Journal of Clinical…
A potential therapy for the most aggressive type of lung cancer in preclinical models
Lung cancer is one of the most prevalent types of cancer, with more than 20,000…
Chemotherapy error: clinicians may be deregistered after incorrect dose
The Guardian Australia. Hospitals failed to tell cancer patients they were under-dosed between July 2014…
Nanoparticle therapy that uses LDL and fish oil kills liver cancer cells
An experimental nanoparticle therapy that combines low-density lipoproteins (LDL) and fish oil preferentially kills primary…
CRT announces license agreement with MSD to develop inhibitors of PRMT5 for cancer and blood disorders
Cancer Research Technology (CRT) – the development and commercialisation arm of Cancer Research UK – has…
New class of drug slows growth of castration-resistant prostate cancer cells
A first-in-class sphingosine kinase 2 inhibitor slowed the growth of castration-resistant prostate cancer cells, in…